Retinoic acid-receptor-related orphan receptor (ROR) α is a nuclear receptor involved in many pathophysiological processes such as cerebellar ataxia, inflammation, atherosclerosis and angiogenesis. In the present study we first demonstrate that hypoxia increases the amount of Rora transcripts in a wide panel of cell lines derived from diverse tissues. In addition, we identified a functional promoter sequence upstream of the first exon of the human Rora gene, spanning − 487 and − 45 from the translation initiation site of RORα1. When cloned in a luciferase reporter vector, this sequence allowed the efficient transcription of the luciferase gene in several cell lines. Interestingly, the activity of the Rora promoter was enhanced by hypoxia in HepG2 human hepatoma cells, and this effect was dependent on an HRE (hypoxia response element) spanning from − 229 to − 225. Using electrophoretic-mobility-shift assays, we showed that HIF-1 (hypoxia-inducible factor 1), which plays a key role in the transcriptional response to hypoxia, bound to this HRE. Overexpression of HIF-1α increased the activity of the Rora promoter through the HRE. Overexpression of a dominantnegative form of HIF-1α producing transcriptionally inactive HIF-1α/HIF-1β dimers abolished hypoxic activation of the Rora promoter. This indicated that HIF-1 is involved in the response of RORα to hypoxia. Taken together, our data reveal Rora as a new HIF-1 target gene. This illustrates, at the molecular level, the existence of cross-talk between signalling pathways mediated by HIF-1 and those mediated by nuclear receptors.
INTRODUCTION
Reduced oxygen availability (hypoxia) is an important component of many physiological (e.g., embryonic development, angiogenesis) and pathological (e.g., organ ischaemia, cancer) processes. In response to hypoxia, the expression of a wide variety of genes, including those involved in angiogenesis, erythropoiesis and glycolysis, is altered. Undoubtedly, HIF-1 (hypoxia-inducible factor 1) plays a key role in the transcriptional control of gene expression in response to hypoxia (for reviews, see [1] [2] [3] . HIF-1 is a heterodimer composed of two subunits, HIF-1α and HIF-1β, both belonging to the Per-ARNT-Sim family of basic helix-loop-helix transcription factors [4] (Per and Sim are the Drosophila proteins Period and Single-minded, and ARNT is aryl hydrocarbon receptor nuclear translocator). HIF-1β is a constitutive nuclear protein. By contrast, the HIF-1α protein is maintained at a low level in normoxic cells through its rapid proteasomal degradation [5] . The O 2 /Fe 2+ -dependent prolyl-hydroxylation of HIF1-α provides recognition for the polyubiquitination complex containing pVHL (von HippelLindau protein) [6] [7] [8] . Recent elegant studies pointed to the PHD2 (HIF prolyl hydroxylase 2) as the key oxygen sensor which controls steady-state levels of HIF-1α [9] [10] [11] . The stabilization of HIF-1α in hypoxic cells allows its nuclear translocation and formation of the transcriptionally active HIF-1α/β heterodimer that, upon binding to specific DNA sequences, stimulates the expression of target genes. Other signalling pathways co-operate with the HIF pathway to achieve a finely tuned response to hypoxia. This is well documented for the phosphoinositide 3-kinase and the mitogen-activated protein kinase pathways (for a review, see [12] ). Also, several studies, often based upon clinical observations, revealed the existence of cross-talk between signalling pathways mediated through nuclear receptors (e.g., androgen receptor, peroxisome-proliferator-activated receptors α and γ , glucocorticoid receptor) and those governing the response to hypoxia [13] [14] [15] [16] [17] [18] [19] .
RORα (retinoic acid-receptor-related orphan receptor α; NR1F1 in the unified nomenclature [20] ) is a transcription factor belonging to the nuclear hormone receptor superfamily (for a review, see [21] ). It is closely related to RARα (retinoic acid receptor α) [22, 23] . RORα is a potent transcriptional activator that, most often, binds as a monomer to a RORE (ROR response element) composed of a 6-bp A/T-rich sequence immediately preceding a half-site core 5 -PuGGTCA-3 motif [23] [24] [25] [26] (Pu = A or G). The Rora gene is located on human chromosome 15q21-q22 and on mouse chromosome 9 [27] . The Rora gene generates four isoforms (RORα1-4) that share common DNA and ligand-binding domains, but differ only by their N-terminal sequences encoded by first exons specific to each of the isoforms [22, 23, 28, 29] . The Rora transcripts are widely distributed in different organs, including brain, heart, liver, testis and skin [22] , suggesting that this receptor has physiological functions in several cell types. RORα4 is the most widespread isoform [22] , whereas RORα1 is predominantly detected in a limited number of organs such as the cerebellum [30] . In vivo studies corroborated the role of RORα in the regulation of diverse physiological and pathophysiological processes (for reviews, see [31, 32] ). Similar severe phenotypes are observed in mice where the Rora gene has been invalidated by homologous recombination [30, 33] and in staggerer mice. In the latter, a spontaneous mutation in Abbreviations used: DMEM, Dulbecco's modified Eagle's medium; DN, dominant-negative; HIF, hypoxia-inducible factor; HRE, hypoxia response element; mut, mutated; IRNEM, Institut fédératif de recherche Necker Enfants-Malades; ROR, retinoic acid-receptor-related orphan receptor; RORE, ROR response element; RT-PCR, reverse-transcription PCR; wt, wild-type. 1 To whom correspondence should be addressed (email danan@necker.fr).
the ligand-binding domain induces a frameshift that results in a protein truncated in its C-terminal part and which lacks any transcriptional activity [28, 29] . These animals suffer from severe cerebellar ataxia caused by massive neurodegeneration of Purkinje cells [30, 33, 34] . Moreover, the phenotype of these mice revealed that RORα is crucially involved in the susceptibility to atherosclerosis [35, 36] and in regulating the inflammatory and immune responses [37, 38] , myogenesis [39] , bone formation [40] and post-ischaemic angiogenesis [41] . Recent experiments identified cholesterol or a cholesterol derivative as a ligand for RORα [42] . However, little is known regarding the stimuli and the transcription factors regulating Rora gene expression. We had previously shown that hypoxia stimulates RORα expression and transcriptional activity in hepatic cells [43] . In the present study we report that Rora expression was up-regulated by hypoxia in a wide panel of cell lines from different tissues and species. This strongly suggested that RORα participates in the response to hypoxia. We also showed that RORα is a new target for HIF-1 that acts upon binding to an hypoxia response element (HRE) that we fully characterized in the promoter region of the human Rora gene and which is conserved in the mouse. [43] . PC12 cells were cultured in DMEM medium supplemented with 10 % (v/v) heat-treated horse serum, 5 % (v/v) heat-treated fetal bovine serum, 100 µg/ml gentamycin and 2.5 µg/ml fungizone. NT2 cells were cultured a 1:1 mixture of DMEM and Ham's F12 medium with GlutaMAX TM -I supplemented with 5 % (v/v) fetal bovine serum, 100 µg/ml gentamycin, and 2.5 µg/ml fungizone. Hypoxic treatment was performed for 24 h in sealed chambers, exactly as described in [44] . Final oxygen concentrations of 10, 2 and 0.1 % were used.
RNA analysis
Total RNA was isolated using TRIZOL TM LS reagent (Invitrogen). Total RNA was reverse-transcribed and subsequently amplified by PCR using an iCycler thermal cycler (Bio-Rad, Marnes La Coquette, France) exactly as described in [43] . Real-time quantitative PCR was carried out with the LightCycler Instrument using the LightCycler FastStart DNA Master SYBR Green I kit for detection of PCR products (Roche Molecular Biochemicals, Mannheim, Germany), according to the manufacturer's guidelines. Final concentrations of MgCl 2 and primers were 3 mM and 0.5 µM respectively. Sequences of primers used to simultaneously amplify all the Rora transcripts or to specifically amplify the Rora1 and the Rora4 transcripts have been described [43] . The amount of β-actin transcripts was evaluated as a control using the β-actin forward primer 5 -TGACCCAGATCATGTT-TGAGACC-3 and the β-actin reverse primer 5 -GGATGTCC-ACGTCACACTTCATG-3 (fragment size 513 bp).
Vectors, transient transfection and luciferase assay
The DNA sequences from the human Rora gene were obtained from the UCSC genome browser database (http://genome.ucsc. edu/cgi-bin/hgGateway) using the June 2002 freeze. Fragments covering region − 3051 to − 45 and − 487 to − 45 relative to the translation initiation site of RORα1 were obtained by PCR using the hRORa-3051 primer (5 -CGATACGCGTGGGAAATG-AGAGCTGTAGTTCAGG-3 ) for the hRORa-3051/-45 sequence, the hRORa-487 primer (5 -GTACACGCGTCTCAGA-AGTAGGCACGGAATCATC-3 ) for the hRORa-487/-45 sequence and the common hRORa-45 primer (5 -TGAGAGAT-CTCCCTCTATCTTCTGTTTTCAGAGC-3 ). PCR amplification was carried out using Platinum Pfx DNA polymerase (Invitrogen). PCR amplification products were then cloned in the BglII-MluI restriction sites in the polylinker region of the promoterless pGL3-basic luciferase reporter vector (pGL3-Luc) from Promega. The constructions containing the − 3051/− 45 and − 487/− 45 sequences are referred to as p(− 3051)Rora-Luc and p(− 487)RoraLuc respectively. Site-directed mutagenesis of the putative HRE located between nucleotides − 229 and − 225 from the translation initiation site of the RORα1 isoform (C −237 GCA-CACACACGTCCACCCAGA −216 → C −237 GCACACACTTTT-CCACCCAGA −216 ) was done using the QuikChange SiteDirected Mutagenesis Kit (Stratagene). The pcDNA3-HIF1α, pcDNA3-HIF1β and pcDNA3-HIF1αDN expression vectors, allowing expression of HIF1-α, HIF-1β and HIF1-α-DN, a DN (dominant-negative) form of HIF1-α, respectively, have been described [45, 46] . The pcDNA3 empty vector was from Invitrogen.
Transient transfection experiments were done using the calcium phosphate method, and luciferase activity was assayed 48 h later as described [47] . For hypoxic treatment, in order to optimize reproducibility, each calcium phosphate/DNA precipitate was split into two equal parts that were spread over two plates of cells. At 24 h after transfection, one plate was incubated under hypoxia while the other was incubated under normoxia as a control. Luciferase activities were measured 24 h later. Activities corresponding to cells cultured under hypoxia were expressed relative to those of control cells cultured under normoxia. For cotransfection experiments, care was taken to keep constant the total amount of transfected DNA using the empty pcDNA3 vector.
Electrophoretic-mobility-shift assays
Unlabelled HIF-1α and HIF-1β proteins were obtained in vitro from the pcDNA3-HIF1α and pcDNA3-HIF1β vectors using the TNT-T7 Quick coupled transcription/translation kit (Promega). Aliquots (1 µl) of the programmed lysates were incubated at room temperature in a 15 µl reaction mixture containing 15 mM Tris/HCl, pH 7.5, 50 mM KCl, 15 mM NaCl, 1 mM MgCl 2 , 0.03 mM EDTA, 5 mM dithiothreitol, 7 % (v/v) glycerol, 50 ng of poly(dI-dC), and 150 ng of a mix of unspecific single-stranded oligonucleotides. A 0.3 ng (10 000 c.p.m.) portion of the doublestranded oligonucleotide, labelled by fill-in with the klenow polymerase and [α-
32 P]dATP (3000 Ci/mmol; Amersham), was added 5 min later. Binding was then allowed to proceed for 15 min at room temperature. For competition experiments, doublestranded oligonucleotides were added simultaneously with the labelled probe. Electrophoresis was performed at 200 V for 2 h 20 min at 15
• C in 0.25 × TBE buffer (1 × TBE is 45 mM Tris/borate/1 mM EDTA) on a native 5%-(w/v)-polyacrylamide gel that had been pre-run for 2 h under the same conditions. The gels were then fixed for 15 min in 20 % (v/v) ethanol/10 % (v/v) acetic acid, dried, and submitted to autoradiography.
Statistical analysis
Results are expressed as means + − S.E.M. for the number of experiments indicated in each case. Statistical analysis was carried out using the ANOVA test [48] . Differences were considered to be significant at P < 0.01.
RESULTS AND DISCUSSION
In order to determine whether the stimulatory effect of hypoxia on Rora gene expression is a general phenomenon, we analysed the effect of hypoxia on the amount of Rora transcripts in various cell types. As evidenced by our real-time quantitative RT-(reverse-transcription) PCR experiments, there were 15-25-fold more Rora transcripts in HepG2 human hepatoma cells ( Figure 1A ) and COS-7 monkey kidney cells ( Figure 1B ) cultured for 24 h under hypoxia (2 or 0.1 % O 2 ) than in control cells cultured under normoxia (20 % O 2 ). This effect was specific, since the level of β-actin-gene transcripts was not affected by the hypoxic treatment (Figure 1 ). The amount of Rora transcripts was also specifically increased by hypoxia in all the other cell lines analysed, namely Hep3B human hepatoma cells, Caco-2 human colorectal adenocarcinoma cells, T47D human breast-carcinoma cells, HeLa human cervical-adenocarcinoma cells, PC12 rat pheochromocytoma cells and NT2 human teratocarcinoma cells (results not shown). These results strongly suggested that the stimulatory effect of hypoxia on Rora gene expression is a general phenomenon that is dependent neither on the cell type nor on the species. In agreement with our results, others have reported a transient up-regulation of the Rora transcripts by hypoxia in human aortic smooth-muscle cells and human endothelial cells [49] . The Rora transcripts are also transiently up-regulated in vivo by ischaemia in the mouse hindlimb [41] . We next evaluated whether the expression of specific RORα isoforms is up-regulated by hypoxia. In COS-7 cells in which RORα1 and RORα4 isoforms are detected, the amount of both the Rora1 and Rora4 transcripts was increased under hypoxia (2 or 0.1 % O 2 , 24 h), as compared with normoxia (20 % O 2 , 24 h) ( Figure 1C) . We concluded that the expression of both the RORα1 and RORα4 isoforms is upregulated by hypoxia.
Since nothing was known about the cis-and trans-acting elements controlling the transcription of the Rora gene, we first checked whether DNA fragments located upstream from the first exon of the human Rora gene, which encodes the 5 part of the Rora1 transcript, contain a promoter activity. To this aim, we cloned the genomic sequences located between nucleotides − 3051 and − 45, and between nucleotides − 487 and − 45 upstream from the translation initiation site of RORα1 in the promoter-less pGL3-Luc reporter vector. Transient transfection experiments in HepG2 cells showed that both the p(− 3051)RoraLuc and the p(− 487)Rora-Luc constructs have a much higher transcriptional activity (about 20-and 50-fold respectively) than that of the promoter-less pGL3-Luc vector (Figure 2A ). This indicated that the − 487-to-− 45 Rora genomic sequence contains a promoter active in HepG2 human hepatoma cells. Similar results were obtained with other cell types, such as HeLa, COS-7, and CHO (Chinese-hamster ovary) cells (results not shown). This indicated that the Rora promoter is active in cells of widespread origin. This result fits very well with those from the computer-assisted analysis we performed to search for putative promoters in the human Rora gene using the PromoterInspector program (Genomatix Software GmbH, Munich, Germany). It showed that the region between nucleotides − 295 and − 64 from the translation initiation site of RORα1 has strong characteristics common to promoters lacking the classical TATA box. Interestingly, similar data were obtained when analysing the corresponding region of the Rora gene in mouse chromosome 9. Taken together, these data indicated that a functional promoter for the Rora gene lies in the proximal upstream region of exon 1 in man and probably in the mouse.
To gain further insight into the mechanisms by which hypoxia up-regulates Rora gene expression, we tested the effect of hypoxia on the transcriptional activity of the p(− 487)Rora-Luc construct in HepG2 cells, which are widely used as a convenient cellular model for analysing the effects of hypoxia on gene expression. Hypoxic treatment (2 % O 2 ) resulted in a 2.5-fold enhancement of the activity of the p(− 487)Rora-Luc construct, as compared with the normoxic (20 % O 2 ) condition ( Figure 2B ). This indicated that the effect of hypoxia on RORα expression is, at least in part, transcriptional and that the − 487-to-− 45 Rora promoter region is involved in this regulation. This prompted us to carefully analyse the Rora promoter region for a putative HRE. We identified a putative HRE sequence (CACGT) between nucleotides − 229 and − 225 relative to the translation initiation site of RORα1. We mutated (mut) the − 229-to-− 225 HRE in three crucial nucleotides (CTTTT) to obtain the pmut(− 487)Rora-Luc construct. This mutation did not alter the basal activity of the − 487-to-− 45 Rora promoter, because luciferase activity of the pmut(− 487)Rora-Luc vector was about 1.18-fold that of the p(− 487)Rora-Luc vector. We found that the − 229-to-− 225 HRE mediated the response of the Rora promoter to hypoxia. Indeed, the stimulatory effect of hypoxia on the activity of p(− 487)Rora-Luc was found dependent on the integrity of the − 229-to-− 225 HRE, because the pmut(− 487)Rora-Luc construct was no longer sensitive to hypoxia ( Figure 2B ).
To test whether the HIF-1α/β heterodimer binds to the HRE identified within the Rora promoter, we used electrophoreticmobility-shift assays with in-vitro-synthesized HIF-1α and -1β proteins. A specific DNA-protein complex with a retarded migration was formed exclusively when both the HIF-1α-and HIF-1β-programmed lysates were incubated together with the 32 P-labelled probe covering the wt (wild-type) Rora HRE (Figure 3, lanes 4 and 13) . The binding of the HIF-1α/β heterodimer to the probe was specific, since it was competed for by an excess of the unlabelled wt-Rora-HRE oligonucleotide (Figure 3, lanes 5-8) , but not with the mut-Rora-HRE mutated oligonucleotide (Figure 3, lanes 9-12) . In the same manner, the binding of the HIF-1α/β heterodimer to the wt-Rora-HRE probe was no longer detected when competition was done with an excess of the wt-Epo-HRE oligonucleotide [50] , which bears the well-characterized HIF-binding site of the erythropoietin (Epo) gene enhancer (Figure 3, lane 14) , but not with the mutEpo-HRE mutated oligonucleotide (Figure 3, lane 15) . These 4-15) . Unprogrammed reticulocyte lysate was used as a control (lane 1) and to keep the total volume of lysate at 2 µl (lanes 2 and 3). Competition assays were carried out by incubating the radiolabelled wt-Rora-HRE probe with the HIF-1α and HIF-1β programmed lysates in the presence of unlabelled wt-Rora-HRE (lanes 5-8) or mutRora-HRE (lanes 9-12) double-stranded oligonucleotides at a 10-, 25-, 50-or 100-fold molar excess. A 100-fold molar excess of the wt-Epo-HRE (lane 14) or mut-Epo-HRE (lane 15) double-stranded oligonucleotides was also used. The arrow points to the specific HIF-1-probe complexes. The asterisk (*) indicates an unrelated complex formed with proteins present in the unprogrammed lysate. Sequences of the oligonucleotides used in the electrophoretic-mobility-shift assays are represented in the upper part of the Figure. The sequence of the HREs is written in bold, the point mutations are underlined, and the nucleotides written in lower case do not belong to the Rora or the Epo sequence and were added for convenience.
data demonstrated that HIF-1 binds to the functionally active HRE present in the Rora promoter.
To determine whether HIF-1 transactivates the Rora promoter, we performed co-transfection experiments in HepG2 cells. Overexpression of the HIF-1α protein alone, or in combination with the HIF-1β protein, resulted in an approx. 10-fold stimulation of the activity of the p(− 487)Rora-Luc vector. By contrast, that of the pmut(− 487)Rora-Luc vector, in which the HRE is mutated, was not altered (Figure 4 ). This strongly suggested that HIF-1 is involved in the upregulation of the Rora promoter activity by hypoxia.
To evaluate directly the involvement of HIF-1 in mediating the effect of hypoxia on the Rora promoter, we used the pcDNA3-HIF1αDN construct, which encodes a DN form of HIF-1α lacking the N-terminal and the C-terminal transactivation domains. HIF-1α-DN heterodimerizes with HIF-1β and this leads to the formation of a non-functional HIF-1 dimer. In cotransfection experiments, expression of the HIF-1α-DN protein abolished the stimulatory effect of hypoxia on the p(− 487)RoraLuc vector. This effect was specific, since the activity of the pmut(− 487)Rora-Luc vector was not altered by the expression of the HIF-1α-DN protein ( Figure 5 ).
Taken together, these results showed that the stimulatory effect of hypoxia on Rora gene transcription is mediated by HIF-1 through the − 229-to-− 225 HRE in the promoter. Interestingly, a sequence identical with the human HRE lies in the corresponding region of the Rora gene in the mouse. This conservation between the two species further underscores the importance of this regulatory sequence in the control of Rora gene expression.
In conclusion, we clearly demonstrate that hypoxia up-regulates expression of the Rora gene in a wide panel of cell types. These findings bring substantial information on the regulation of RORα with potentially interesting physiological and pathological consequences. One may hypothesize that this widely expressed nuclear receptor probably participates in the response to the hypoxic stress by regulating a subset of genes. Characterization of these genes is obviously an exciting challenge. RORα is known to possess anti-inflammatory properties [38] and to play some role in post-ischaemic angiogenesis [41] . We now show that Rora is a hypoxia-responsive gene. Inflammation, hypoxia and angiogenesis are the basis of major pathophysiological processes such as atherosclerosis and cancerogenesis. The protective role of RORα against atherosclerosis is well known [35, 36] . It would not be surprising if RORα also plays some part in the carcinogenetic process. However, further work is required to explore this route. Interestingly, our study reveals Rora as a new HIF-1 target gene. This result fits well with those from a very recent study indicating that the Nur77 orphan nuclear receptor is also a direct target for HIF-1 [51] . These results allow deciphering, at the molecular level, one aspect of the cross-talk between the signalling pathways used to sense and respond to hypoxia and those mediated by nuclear receptors. This is an important step in the extensive characterization of the cross-talk between these two signalling pathways, which may be useful to finely tune both the response to hypoxia and to hormones/nutrients. Such an approach may ultimately allow one to develop new strategies for the efficient treatment of many critical health problems.
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